Menu
Back to Archived Journals » Core Evidence » Volume 8
Review
Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,469 | Dovepress* | 9,240+ | 1,636 | 10,876 | |
| PubMed Central* | 1,229 | 473 | 1,702 | ||
| Totals | 10,469 | 2,109 | 12,578 | ||
|
*Since 30 September 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 2 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar